[Long term follow up after parenteral specific hyposensitization in children (author's transl)].
The long term follow up of 55 children with allergy treated by specific hyposensitization therapy is reported. Hyposensitization therapy had been terminated from 2--7 years previously. The success of treatment was subjectively judged to be satisfactory of good in 62% of the cases. In the group of asthmatic children, asthma attacks had decreased or ceased in 74% of the cases: in children with hay fever only 24% continued to have as many or more symptoms as before treatment. In children with asthma and pollen allergy, the success rate was slightly higher with aqueous extracts (68%) than with pyridine-extracted and alum-precipitated extract administration (43%). Also in children with hay fever symptoms alone the use of aqueous extracts seemed to bring somewhat better results (57% with good or satisfactory success) in comparison with pyridine-extracted and alum-precipitated extracts (45%). Side effects of hyposensitization therapy occured in 29 children (53%).
D000485:Allergens / Q000008:administration & dosage; D001249:Asthma / Q000150:complications / Q000628:therapy*; D002648:Child; D003888:Desensitization, Immunologic / Q000009:adverse effects; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D006255:Rhinitis, Allergic, Seasonal / Q000150:complications / Q000628:therapy*; D012996:Solutions
D000485:Allergens; D012996:Solutions
Spätergebnisse nach parenteraler spezifischer Hyposensibilisierung im Kindesalter